Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1627 1691
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18277524 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | Non-Final OA | LG CHEM, LTD. |
| 18455578 | IMIDAZO[1,2-a]PYRAZINE OR PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND USE THEREOF | Non-Final OA | TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED |
| 19269487 | ANTIBODY-DRUG CONJUGATES USING TWO DIFFERENT TYPES OF TOPOISOMERASE I INHIBITORS | Non-Final OA | ARARIS BIOTECH AG |
| 18717529 | PHARMACEUTICAL COMBINATION COMPRISING ABEMACICLIB AND A PI3K AND/OR A MTOR INHIBITOR FOR THE TREATMENT OF MANTLE CELL LYMPHOMA | Non-Final OA | Board of Regents, The University of Texas System |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy